Showing results (111-120 of 1,283) with videos related to

Sort By:
Pageof 129
Blood|August 1, 1985
Prognostic implications of tumor cell DNA and RNA content in multiple myelomaB Barlogie, R Alexanian, D Dixon, et al.
Cell and Tissue Kinetics|March 1, 1981
A rapid automated stathmokinetic method for determination of in vitro cell cycle transit timesG M Dosik, B Barlogie, R A White, et al.
Cancer Research|November 1, 1979
In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II)J P Bergerat, B Barlogie, W Göhde, et al.
Cancer Research|January 1, 1981
Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosineJ P Bergerat, B Drewinko, P Corry, et al.
Blood|January 15, 1994
Limited value of myeloablative therapy for late multiple myelomaR Alexanian, M Dimopoulos, T Smith, et al.
Diagnostic Cytopathology|June 1, 1987
A morphologic, immunologic, and cytometric approach to the classification of non-Hodgkin's lymphoma in effusionsR L Katz, P Raval, J T Manning, et al.
Neurology|October 22, 1998
Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatmentS A Rudnicki, S I Harik, M Dhodapkar, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1979
Cell-cycle phase-dependence of drug-induced cycle progression delayW Göhde, M Meistrich, R Meyn, et al.
AJNR. American Journal of Neuroradiology|April 6, 2001
CT-guided biopsy of focal lesions in patients with multiple myeloma may reveal new and more aggressive cytogenetic abnormalitiesR Avva, R L Vanhemert, B Barlogie, et al.
Blood|February 1, 1988
Plasma cell karyotype in multiple myelomaJ Gould, R Alexanian, A Goodacre, et al.
Pageof 129